1-5 of 5
Authors: Javier Marco-Sanz
Journal Article
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models Open Access
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1509–1525, https://doi.org/10.1093/neuonc/noae066
Published: 30 March 2024
Journal Article
DIPG-04. TUMOR CELL-INTRINSIC TIM-3 PROMOTES DIFFUSE INTRINSIC PONTINE GLIOMA TUMORIGENESIS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i13, https://doi.org/10.1093/neuonc/noad073.051
Published: 12 June 2023
Journal Article
DIPG-10. DELTA-24-RGDOX PROMOTES ANTITUMOR IMMUNE RESPONSE IN DMG MODELS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i14–i15, https://doi.org/10.1093/neuonc/noad073.057
Published: 12 June 2023
Journal Article
EXTH-58. UNRAVELING THE MECHANISMS UNDERLYING THE THERAPEUTIC EFFICACY OF TIM-3 BLOCKADE IN DIPGS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii222, https://doi.org/10.1093/neuonc/noac209.856
Published: 14 November 2022
Journal Article
IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i85, https://doi.org/10.1093/neuonc/noac079.311
Published: 03 June 2022
